0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Picture of the Month FREE

[+] Author Affiliations

Section Editor: Walter W. Tunnessen, MD

More Author Information
Arch Pediatr Adolesc Med. 2001;155(7):846. doi:10.1001/archpedi.155.7.845.
Text Size: A A A
Published online

DENOUEMENT AND DISCUSSION: MULTIPLE ENDOCRINE NEOPLASIA 2B SYNDROME

Figure 1. The lips are thick with nodules on the buccal mucosa at the angles of the mouth.

Figure 2. Nodules are noted lateral to an indented scar at the tip of the tongue from previous surgery.

Figure 3. DNA sequencing analysis of exon 16 of the RET proto-oncogene of the patient, her mother, sister, and control. A T→C transition in codon 918 is present in the patient; findings for the mother and sister were normal. This single point mutation results in the substitution of threonine for methionine (M918T) in the tyrosine kinase domain of the RET protein.

Multiple endocrine neoplasia 2B syndrome (MEN 2B) is a rare disorder inherited as an autosomal dominant trait. It is characterized by multiple mucosal neuromas, MTC, and pheochromocytoma.1

CLINICAL FEATURES

Characteristic findings on physical examination include elongated facies; mucosal neuromas on the lips, eyelids, buccal mucosa, tongue, palate, and intestinal mucous membranes; thickened medullated corneal nerves on slitlamp examination; marfanoid habitus; kyphoscoliosis; joint laxity; and pes cavus.2,3 Gastrointestinal manifestations, such as abdominal distension, feeding problems, dysphagia, vomiting, chronic constipation, intermittent abdominal pain, megacolon, and ganglioneuromatosis, may be seen in infancy.3 Constipation may suggest Hirschsprung disease.

Mucosal neuromas and MTC occur in all affected patients. A marfanoid habitus is present in 75% of patients, while enteric ganglioneuromatosis is found in more than 40% and pheochromocytoma in 50% of those affected.1 A main criterion for differentiation of MEN 2B from MEN 2A is the absence of mucosal neuromas in the latter.

Although full-blown manifestations of this disorder should facilitate recognition, in infancy or early childhood, when only gastrointestinal signs and symptoms are present, the diagnosis may be difficult. MEN 2B should be included in the differential diagnosis of chronic constipation in young children, and careful evaluation for clinical findings should be performed and genetic testing considered.3

MOLECULAR BASIS

Genetic alterations of the RET proto-oncogene have been identified in 95% to 98% of patients with MEN 2B, with a germline mutation most frequently at codon 9184,5 and, rarely, at codon 883.6 Screening is hampered because at least 50% of the cases are caused by de novo mutations.5

SURGICAL THERAPY

Total thyroidectomy is the primary treatment of MTC,7 which is almost universally bilateral and multifocal in MEN 2B cases and is associated with a high incidence of metastasis at the time of diagnosis.8 Extensive lymphadenectomy should be performed at the time of initial thyroidectomy, and reoperative lymphadenectomy must be considered in patients with persistently elevated calcitonin levels after thyroidectomy.7 Monitoring serum calcitonin levels is useful in identifying the occurrence of metastatic disease.

Early detection of individuals at risk for MEN 2B by genetic screening allows prophylactic thyroidectomy to be carried out before metastasis occurs. Because MTC has been diagnosed in a 6-month-old infant with MEN 2B,8 and metastatic MTC has been found in children younger than 5 years,9 prophylactic total thyroidectomy before age one2 or five10 years has been proposed.

PROGNOSIS

The 5-year survival rate for MTC is 70% to 80%. Good prognostic factors are young age at diagnosis, female sex, occurrence in families, and tumor confinement to the thyroid gland.11 Periodic evaluation for pheochromocytoma should continue indefinitely after MEN 2B is identified.

Accepted for publication May 3, 2000.

This research was supported by NSC grant 88-2314-B-195-012 from the National Science Council, Executive Yuan, Taiwan.

Reprints: Tsen-Long Yang, MD, Department of Surgery, Mackay Memorial Hospital, 92 Chung-San N Rd, Section 2, Taipei 10449, Taiwan.

Morrison  PJNevin  NC Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). J Med Genet. 1996;33779- 782
O'Riordain  DSO'Brien  TCrotty  TB  et al.  Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery. 1995;118936- 943
de Krijger  RRBrooks  Avan der Harst  E  et al.  Constipation as the presenting symptom in de novo multiple endocrine neoplasia type 2B. Pediatrics. 1998;102405- 408
Hofstra  RMWLandsvater  RMCeccherini  I  et al.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 1994;367375- 376
Carlson  KMDou  SChi  D  et al.  Single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2 B. Proc Natl Acad Sci U S A. 1994;911579- 1583
Gimm  OMarsh  DJAndrew  SD  et al.  Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab. 1997;823902- 3904
Fleming  JBLee  JEBouvet  M  et al.  Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg. 1999;230697- 706
O'Riordain  DSO'Brien  TWeaver  AL  et al.  Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery. 1994;1161017- 1023
Kaufman  FRRoe  TFIsaacs  H  JrWeitzman  JJ Metastatic medullary thyroid carcinoma in young children with mucosal neuroma syndrome. Pediatrics. 1982;70263- 267
Eng  CPonder  BAJ Multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Grossman  Aed.Clinical Endocrinology 2nd ed. Oxford, England Blackwell Science Ltd1998;635- 650
Saad  MFOrdonez  NGRashid  RK  et al.  Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore). 1984;63319- 342

Tables

References

Morrison  PJNevin  NC Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). J Med Genet. 1996;33779- 782
O'Riordain  DSO'Brien  TCrotty  TB  et al.  Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery. 1995;118936- 943
de Krijger  RRBrooks  Avan der Harst  E  et al.  Constipation as the presenting symptom in de novo multiple endocrine neoplasia type 2B. Pediatrics. 1998;102405- 408
Hofstra  RMWLandsvater  RMCeccherini  I  et al.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 1994;367375- 376
Carlson  KMDou  SChi  D  et al.  Single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2 B. Proc Natl Acad Sci U S A. 1994;911579- 1583
Gimm  OMarsh  DJAndrew  SD  et al.  Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab. 1997;823902- 3904
Fleming  JBLee  JEBouvet  M  et al.  Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg. 1999;230697- 706
O'Riordain  DSO'Brien  TWeaver  AL  et al.  Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery. 1994;1161017- 1023
Kaufman  FRRoe  TFIsaacs  H  JrWeitzman  JJ Metastatic medullary thyroid carcinoma in young children with mucosal neuroma syndrome. Pediatrics. 1982;70263- 267
Eng  CPonder  BAJ Multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Grossman  Aed.Clinical Endocrinology 2nd ed. Oxford, England Blackwell Science Ltd1998;635- 650
Saad  MFOrdonez  NGRashid  RK  et al.  Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore). 1984;63319- 342

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
[Prophylactic thyroidectomy in medullary thyroid cancer]. Bull Acad Natl Med 2012;196(7):1247-58; discussion 1258-60.